| 05/09 | ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial .. | AQ |
| 05/09 | ARCTURUS THERAPEUTICS : Q1 Earnings Snapshot | AQ |
| 05/09 | Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progre.. | BU |
| 05/05 | CORRECTING and REPLACING GRAPHIC Arcturus Reports Strong Three-Month Durability Results.. | BU |
| 04/27 | Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corpor.. | BU |
| 04/22 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 04/20 | ARCTURUS THERAPEUTICS : Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154.. | PU |
| 04/20 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Terminat.. | AQ |
| 04/20 | Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Prima.. | BU |
| 03/28 | Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disea.. | AQ |
| 03/25 | Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disea.. | BU |
| 03/18 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 03/14 | Arcturus Therapeutics to Participate in the Barclays Global Healthcare Conference | BU |
| 03/01 | ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial .. | AQ |
| 02/28 | ARCTURUS THERAPEUTICS : Announces Fourth Quarter and Full Year 2021 Financial Update and P.. | PU |
| 02/28 | ARCTURUS THERAPEUTICS : Q4 Earnings Snapshot | AQ |
| 02/28 | Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and .. | BU |
| 02/21 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4) | AQ |
| 02/18 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 02/17 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for.. | AQ |
| 02/16 | Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and .. | BU |
| 02/11 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 02/08 | Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare C.. | BU |
| 01/25 | Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Respo.. | BU |
| 01/24 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4) | AQ |
| 01/24 | Arcturus Therapeutics Updates Data from ARCT-154 and ARCT-165 Booster Clinical Trial De.. | BU |
| 01/21 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 01/11 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Regulation FD Disclosure (form 8-K) | AQ |
| 2021 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(4) | AQ |
| 2021 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 2021 | Arcturus Therapeutics Reports New Data and Provides Additional Updates from ARCT-154 an.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directo.. | PU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Change in Directors or Principal Officers, Amendment.. | AQ |
| 2021 | Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Direct.. | BU |
| 2021 | Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference | BU |
| 2021 | Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial .. | AQ |
| 2021 | Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre.. | PU |
| 2021 | ARCTURUS THERAPEUTICS : Q3 Earnings Snapshot | AQ |
| 2021 | Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre.. | BU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Financia.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : to Report Third Quarter 2021 Financial Results and Provide Corpora.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Announces Leadership Appointments | BU |
| 2021 | ARCTURUS THERAPEUTICS : Reports Inducement Grant Under Nasdaq Listing Rule 5635(4) | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into.. | BU |
| 2021 | Combined Market Cap of Top Five mRNA Companies hit $265B, a Fivefold Increase in a Year | AQ |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement, Creation.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Meeting with President of Vietnam and CEO of Vingroup to.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval from Vietnam Ministry of Health to Proceed into.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : to Participate in Citi's 16th Annual BioPharma Virtual Conference .. | BU |
| 2021 | ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences | BU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Termination of a Material Definitive Agreement, Chan.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Late Filing Notice (SEC Filing - NT 10-Q) | PU |
| 2021 | ARCTURUS THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Re.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Q2 Earnings Snapshot | AQ |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Results of Operations and Financial Condition, Regul.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Second Quarter 2021 Financial Results and mRNA Vaccine a.. | BU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Entry into a Material Definitive Agreement (form 8-K.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval of Singapore Clinical Trial Application to Adva.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval of a Clinical Trial Application to Advance ARCT.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Collaborates with Vingroup to Establish Manufacturing Facility in .. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval of Singapore Clinical Trial Application to Adva.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Announces Approval of a Clinical Trial Application to Advance ARCT.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Collaborates with Vingroup to Establish Manufacturing Facility in .. | BU |
| 2021 | ARCTURUS THERAPEUTICS : Announces Regulatory Approval to Proceed with Phase 2 Study of ARC.. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : Announces Regulatory Approval to Proceed with Phase 2 Study of ARC.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : to Report Second Quarter 2021 Financial Results and Provide Corpor.. | BU |
| 2021 | ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences | BU |
| 2021 | ARCTURUS THERAPEUTICS HOLDINGS INC. : Submission of Matters to a Vote of Security Holders .. | AQ |
| 2021 | ARCTURUS THERAPEUTICS : to Present at Upcoming Investor and Scientific Conferences | BU |
| 2021 | PRIMORDIAL GENETICS : Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase .. | PR |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
